Oyo Raises Close to $175 Mn in Series G Round

It included investors like InCred Wealth, Patient Capital, J&A Partners, the family office of Mankind Pharma promoters, and ASK Financial Holdings.

Singapore-based Patient Capital contributed as much as Rs 830 crore ($100 million), an entity managed by founder and CEO of Oyo, Ritesh Agarwal.

J&A Partners invested Rs 120 crore ($14 million) while ASK Financial Holdings put in Rs 14 crore ($1.65 million).

The funds would be utilized to drive Oyo’s growth plans, such as expansion across the world and acquisitions, and for enhancing business plans.

Oyo has shown tremendous resilience and agility in times when the markets were difficult. In May, founder Ritesh Agarwal announced the company achieved its first annual net profit of Rs 100 crore in FY24.

The recent funding round thus underlines the confidence of the investors in the strategic direction and growth prospects of Oyo.